Novo Nordisk | NVO - 流動負債





流動負債 変化する 日付
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bausch Health Companies USD 4.53B 350M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Merck USD 26.94B 1.38B 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novo Nordisk DKK 215.66B 18.7B 2025-12
Novo Nordisk DKK 32.79B 203.33B 2025-06
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 1.01B 132.4M 2025-12
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Zoetis USD 2.24B 428M 2025-12